Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Mental Conditions”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00137280
What this trial is testing

Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)

Who this might be right for
SchizophreniaChronic IllnessWeight Gain+1 more
VA Office of Research and Development 1,067
Not applicableStudy completedNCT01602263
What this trial is testing

Transcranial Direct Current Stimulation (tDCS) and Cognitive Processing

Who this might be right for
AphasiaAutismSchizophrenia
Johns Hopkins University 307
Testing effectiveness (Phase 2)Study completedNCT02970877
What this trial is testing

Stool Transplantation for Treatment of Insulin Resistance in Morbidly Obese Patients

Who this might be right for
Obesity, MorbidInsulin Resistance
Johane Allard 29
Early research (Phase 1)Not Yet RecruitingNCT06644573
What this trial is testing

Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia

Who this might be right for
Chronic InsomniaSleep DeprivationREM Behavior Disorder+34 more
Nyree Penn 100
Post-approval studies (Phase 4)WithdrawnNCT00786318
What this trial is testing

Ziprasidone vs Standard Therapy for Agitated Patients in the ED

Who this might be right for
PsychosisAgitationDelirium
George Washington University
Large-scale testing (Phase 3)Looking for participantsNCT06482554
What this trial is testing

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

Who this might be right for
ApathySchizophreniaSchizophrenia; Psychosis
Louisiana State University Health Sciences Center Shreveport 80
Not applicableStudy completedNCT05603260
What this trial is testing

Imagery Interventions for Auditory Vocal Hallucinations

Who this might be right for
Auditory HallucinationHearing Voices When No One is TalkingPsychosis
Hella Janssen 32
Not applicableStudy completedNCT06109753
What this trial is testing

Ergonomic Benefits From Robotically Assisted Laparoscopy for Hysterectomies and Other Indications

Who this might be right for
Musculoskeletal Diseases or Conditions
University Hospital Tuebingen 4
Testing effectiveness (Phase 2)Study completedNCT07116694
What this trial is testing

Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder

Who this might be right for
Bipolar I DisorderBipolar II DisorderSchizophrenia+3 more
BioXcel Therapeutics Inc 33
Not applicableUnknownNCT00979888
What this trial is testing

Study of How Caregivers Help Patients Cope With Respiratory and Other Symptoms Caused by Lung Cancer

Who this might be right for
Anxiety DisorderDepressionDyspnea+2 more
University of Manchester 80
Large-scale testing (Phase 3)Ended earlyNCT01122927
What this trial is testing

Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.

Who this might be right for
Adolescent SchizophreniaChild or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Otsuka Pharmaceutical Development & Commercialization, Inc. 524
Post-approval studies (Phase 4)Study completedNCT01400113
What this trial is testing

Treating Acutely Agitated Patients With Asenapine Sublingual Tablets

Who this might be right for
Agitation
Unity Health Toronto 120
Very early researchStudy completedNCT02531360
What this trial is testing

Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies

Who this might be right for
Alzheimer's Disease (AD)Progressive Supranuclear Palsy (PSP)Cortical Basal Syndrome (CBS)+1 more
Molecular NeuroImaging 7
Not applicableStudy completedNCT00444301
What this trial is testing

Pain Assessment, Incidence & Nature in Heart Failure

Who this might be right for
Heart Diseases
PC-HEART 349
Testing effectiveness (Phase 2)UnknownNCT04529226
What this trial is testing

Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis

Who this might be right for
PsychosisIntellectual Disability
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 75
Not applicableStudy completedNCT00001486
What this trial is testing

Genetic Study of Schizophrenia

Who this might be right for
Schizoaffective DisorderSchizophrenia
National Institute of Mental Health (NIMH) 4,914
Not applicableLooking for participantsNCT05703711
What this trial is testing

Combining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West Africa

Who this might be right for
PsychosisManiaDepression
University of Washington 360
Early research (Phase 1)Study completedNCT00821444
What this trial is testing

Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules

Who this might be right for
Healthy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 11
Testing effectiveness (Phase 2)Ended earlyNCT00917293
What this trial is testing

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Medicure 53
Large-scale testing (Phase 3)Study completedNCT00240721
What this trial is testing

The Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder

Who this might be right for
Bipolar DisordersMood DisordersAffective Disorders, Psychotic
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 363
Next Page